651 related articles for article (PubMed ID: 32809998)
1. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study.
van der Stelt CA; Vermeulen Windsant-van den Tweel AM; Egberts AC; van den Bemt PM; Leendertse AJ; Hermens WA; van Marum RJ; Derijks HJ
Drug Saf; 2016 Jan; 39(1):79-87. PubMed ID: 26553305
[TBL] [Abstract][Full Text] [Related]
4. Rationalizing prescription via deprescribing in oncology practice.
Raju B; Chaudhary RK; L A; Babu A; Sandeep A; Mateti UV
J Oncol Pharm Pract; 2023 Dec; 29(8):2007-2013. PubMed ID: 37847585
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study.
Fahrni ML; Azmy MT; Usir E; Aziz NA; Hassan Y
PLoS One; 2019; 14(7):e0219898. PubMed ID: 31348784
[TBL] [Abstract][Full Text] [Related]
7. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States.
Brown JD; Hutchison LC; Li C; Painter JT; Martin BC
J Am Geriatr Soc; 2016 Jan; 64(1):22-30. PubMed ID: 26782849
[TBL] [Abstract][Full Text] [Related]
8. Reducing Potentially Inappropriate Medications in Older Adults: A Way Forward.
Bala SS; Chen TF; Nishtala PS
Can J Aging; 2019 Dec; 38(4):419-433. PubMed ID: 30915926
[TBL] [Abstract][Full Text] [Related]
9. Drug Prescribing: Polypharmacy and Deprescribing.
McQuade BM; Campbell A
FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
[TBL] [Abstract][Full Text] [Related]
10. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
Chou J; Tong M; Brandt NJ
J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
[TBL] [Abstract][Full Text] [Related]
11. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
12. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
13. Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation?
Baumgartner AD; Clark CM; LaValley SA; Monte SV; Wahler RG; Singh R
J Clin Pharm Ther; 2020 Jun; 45(3):453-461. PubMed ID: 31873955
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
15. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
[TBL] [Abstract][Full Text] [Related]
16. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
O'Mahony D
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):15-22. PubMed ID: 31790317
[No Abstract] [Full Text] [Related]
17. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact.
McGettigan S; Curtin D; O'Mahony D
Expert Rev Clin Pharmacol; 2023; 16(12):1175-1185. PubMed ID: 37947757
[TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.
Hamilton H; Gallagher P; Ryan C; Byrne S; O'Mahony D
Arch Intern Med; 2011 Jun; 171(11):1013-9. PubMed ID: 21670370
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study.
Sallevelt BTGM; Huibers CJA; Knol W; Puijenbroek EV; Egberts T; Wilting I
BMJ Open; 2020 Feb; 10(2):e033721. PubMed ID: 32075833
[TBL] [Abstract][Full Text] [Related]
20. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
